From the publishers of JADPRO

CAR T-Cell Therapy Resource Center

Advertisement
Case Studies
Hemophagocytic Lymphohistiocytosis Following CAR T-Cell Therapy in a Patient With Multiple Myeloma
Bloodless Medicine Management of a Patient Receiving CAR T-Cell Therapy
Transverse Myelitis With Paraplegia: An Atypical Manifestation of Neurotoxicity Following CAR T-Cell Therapy
CAR T-cell Infusion in an Outpatient Setting: An Ideal Option for Selected Patients When Available
B-Cell Aplasia, Hypogammaglobulinemia Can Result in Serious, Life-Threatening Infections
Neurologic Toxicity Post-CAR T-Cell Therapy and CRS: Differentiating Symptoms and Individual Management
Cardiovascular Events Following CAR T-Cell Therapy Are Common, Especially in Conjunction With CRS
Cytopenias After CAR T-cell Therapy: Varying Predictive Markers, Duration
Identifying CRS in Patients Who Underwent CAR T-Cell Infusion
Advertisement
Case Studies

Hemophagocytic Lymphohistiocytosis Following CAR T-Cell Therapy in a Patient With Multiple Myeloma

Bloodless Medicine Management of a Patient Receiving CAR T-Cell Therapy

Transverse Myelitis With Paraplegia: An Atypical Manifestation of Neurotoxicity Following CAR T-Cell Therapy

Fast Facts

Fast Facts #12: BCMA Targets

Advertisement
Quizzes
Test your knowledge of hemophagocytic lymphohistiocytosis following CAR T-cell therapy in a patient with multiple myeloma
Test your knowledge of bloodless medicine management of a patient receiving CAR T-cell therapy
Test your knowledge of atypical manifestation of neurotoxicity following CAR T-cell therapy